Can a common bile acid pill reverse stomach changes that lead to cancer?

NCT ID NCT06610760

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether ursodeoxycholic acid, a bile acid medication, can reverse gastric intestinal metaplasia—a condition where the stomach lining changes and raises cancer risk. Researchers will give 196 adults without H. pylori infection either the drug or a placebo for 6 months, checking every 4 weeks. The goal is to see if the drug can make the abnormal tissue regress or prevent it from worsening.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ursodeoxycholic acid
What this could lead to
If it works, this could offer a non-invasive way to reverse a precancerous stomach condition, potentially reducing stomach cancer risk.
What could go wrong
This is a phase 4 trial, but the condition is hard to reverse and previous treatments have had mixed results. The benefit may be small or absent, and side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC INTESTINAL METAPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • 989 Hospital of PLA Joint Logistics Support Force

    RECRUITING

    Pingdingshan, Henan, China

  • Ankang Central Hospital

    RECRUITING

    Ankang, Shaanxi, China

  • Hanzhong 3201 Hospital

    RECRUITING

    Hanzhong, Shaanxi, China

  • Shangluo Central Hospital

    RECRUITING

    Shangluo, Shaanxi, China

  • Xi'an Central Hospital

    RECRUITING

    Xi'an, Shaanxi, China

  • Xijing hospital

    RECRUITING

    Xi'an, Shaanxi, 710032, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.